Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy

European Journal of Clinical Investigation

Volumn 32, Issue 2, 2002, Pages 93-99

  Vervoort, Gerald ^a   Elving, L D ^a   Wetzels, J F M ^a   Lutterman, J A ^a   Smits, P ^a   De Pont, J J H H M ^a   Berden, J H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetic nephropathy; Microangiopathy; Sodium lithium countertransport; Type 1 diabetes mellitus

Indexed keywords

ACETYLCHOLINE; FRUCTAN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; LITHIUM ION; SODIUM ION;

ADULT; ARTERIAL PRESSURE; BINDING AFFINITY; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CELL LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FOREARM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ION EXCHANGE; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK ASSESSMENT; SODIUM TRANSPORT; VELOCITY;

ALBUMINURIA; ANTIPORTERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; ERYTHROCYTES; HEMODYNAMIC PROCESSES; HUMANS; ION TRANSPORT; KINETICS; RENAL CIRCULATION; RISK FACTORS;

EID: 0037003190     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00942.x     Document Type: Conference Paper

References (38)

1. The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995;47:1703-20.
2. Deckert T, Poulsen JE. Diabetic nephropathy: fault or destiny? Diabetologia 1981;21:178-83.
3. Viberti GC, Earle K. Predisposition to essential hypertension and the development of diabetic nephropathy. J Am Soc Nephrol 1992;3:S27-33.
4. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease; evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-5.
5. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. BMJ 1987;295:515-17.
6. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-5.
7. Monciotti CG, Semplicini A, Morocutti A, Maioli M, Cipollina MR, Barzon I et al. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM. Diabetologia 1997;40:654-61.
8. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980;302:772-6.
9. Elving LD, Wetzels JFM, de Pont JJHHM, Berden JHM. Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic nephropathy? Kidney Int 1992;41:862-71.
10. + countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review. Eur J Clin Invest 1998;28:339-52.
11. Rutherford PA, Thomas TH, Carr SJ, Taylor R, Wilkinson R. Kinetics of sodium-lithium countertransport activity in patients with uncomplicated type 1 diabetes. Clin Sci 1992;82:291-9.
12. Dowd A, Thomas TH, Taylor R, Wilkinson R. Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients. Diabetologia 1994;37:394-400.
13. West IC, Rutherford PA, Thomas TH. Sodium-lithium countertransport: physiology and function. J Hypertens 1998;16:3-13.
14. Lijnen P, Fenyvesi A, Bex M, Bouillon R, Amery A. Erythrocyte cation transport systems and membrane lipids in insulin dependent diabetes. Am J Hypertens 1993;6:763-70.
15. Rutherford PA, Thomas TH, Laker MF, Wilkinson R. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Eur J Clin Invest 1992;22:719-24.
16. Lopes de Faria JB, Jones SL, Macdonald F, Chambers J, Mattock MB, Viberti G. Sodium-lithium countertransport activity and insulin resistance in normotensive IDDM patients. Diabetes 1992;41:610-15.
17. Carr S, Mbanya JC, Thomas T, Keavey P, Taylor R, Alberti KG et al. Increase in glomerular filtration rate in patients with insulin-dependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 1990;322:500-5.
18. Rongen GA, Smits P, Thien T. N-Monomethyl-L-ARG reduces the forearm vasodilator response to acethylcholine but not to methacholine in humans. J Cardiovasc Pharmacol 1993;22:884-8. Error! Bookmark not defined.
19. Vervoort G, Wetzels JFM, Lutterman JA, van Doorn LG, Berden JHM, Smits P. Elevated skeletal muscle blood flow in non-complicated type 1 diabetes mellitus: The role of nitric oxide and sympathetic tone. Hypertension 1999;34:1080-5.
20. Parving H, Rasmussen SM. Transcapillary escape rate of albumin and plasma Volume in short- and long-term juvenile diabetics. Scan J Clin Lab Invest 1973;32:81-7.
21. Pedrinelli R, Taddei S, Spessot M, Salvetti A. Maximal post-ischaemic forearm vasodilation in human hypertension: a re-assessment of the method. J Hypertens 1987;5:S431-S3.
22. Vervoort G, Lutterman JA, Smits P, Berden JH, Wetzels JF. Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients. J Hypertens 1999;17:1911-16.
23. + countertransport across the erythrocyte membrane (letter). Clin Chem 1997;43:1090-2.
24. + countertransport in diabetes; Methodology and Controversy. J Am Soc Nephrol 1992;3:S41-S9.
25. Demacker PN, Hijmans AG, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980;26:1775-9.
26. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992;41:723-30.
27. Rutherford PA, Thomas TH, Carr SJ, Taylor R, Wilkinson R. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy. Clin Sci 1992;82:301-7.
28. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC. Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988;318:146-50.
29. Rutherford PA, Thomas TH, Hardman T, Lant AF, Wilkinson R. Sodium-lithium countertransport activity is not affected by short-term insulin exposure in vivo or in a physiologic medium in vitro. Metabolism 1993;42:1087-9.
30. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension? J Hypertens 1990;8:139-46.
31. Trevisan R, Nosadini R, Fioretto P, Semplicini A, Donadon V, Doria A et al. Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport. Kidney Int 1992;41:855-61.
32. Mangili R, Zerbini G, Barlassina C, Cusi D, Pozza G. Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney Int 1993;44:127-33.
33. + countertransport and glomerular hyperfiltration in insulin-dependent diabetics. Am J Hypertens 1993;6:534-7.
34. Hardman TC, Lant AF. Controversies surrounding erythrocyte sodium-lithium countertransport. J Hypertens 1996;14:695-703.
35. Hardman TC, Dubrey SW, Leslie RD, Lant AF. Kinetic behaviour of the erythrocyte sodium-lithium countertransporter in non-nephropathic diabetic twins. Metabolism 1996;45:1203-7.
36. Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Stamler J. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport; Gubbio Population Study Research Group. Hypertension 1999;33:887-93.
37. Hardman TC, Dubrey SW, Leslie RD, Lant AF. Erythrocyte sodium-lithium countertransport activity in non-nephropathic diabetic twins. Diabetes Care 1996;19:32-8.
38. Schut NH, Van Arkel EC, Hardeman MR, Bilo HJ, Michels RP, Vreeken J. No decreased erythrocyte deformability in type 1 (insulin-dependent) diabetes, either by filtration or by ektacytometry. Acta Diabetol 1993;30:89-92.